Oral Presentation
Lung cancer immunology: latest research
08:30
Introduction talk
1
OA
08:45
LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features
E. Garrido-Martin(Madrid, Spain)
COI
2
09:00
Regulatory vs. cytotoxic cells in lymph nodes of lung cancer patients resected by TEMLA
J. Domagała-Kulawik(Warszawa, Poland)
COI
3
09:15
Microscopic vessel invasion and visceral pleural invasion are correlated with EMT, cancer stemness and resistance to therapy in lung adenocarcinoma
S. Neri(Kusatsu, Japan)
COI
4
09:30
The prognostic influence of tumor infiltrating M1 and M2 phenotype macrophages in resected non-small cell lung cancer
J. Matulione(Kaunas, Lithuania)
COI
5
09:45
Lymphocyte profile in the BALF from affected lung in comparison to healthy lung and systemic inflammation in lung cancer
J. Domagała-Kulawik(Warszawa, Poland)
COI
6
10:00
Anti-cancer effects of bevacizumab and cisplatin on cancer cell invaded human ex-vivo lung tissue
S. Konzok(Hannover, Germany)
COI
7
. . .